z-logo
Premium
Activation of toll‐like receptors 2 and 4 on CD 34 + cells increases human megakaryo/thrombopoiesis induced by thrombopoietin
Author(s) -
D'Atri Lina Paola,
Rodríguez Camila Sofía,
Miguel Carolina Paula,
Pozner Roberto Gabriel,
Ortiz Wilczyñski Juan Manuel,
Negrotto Soledad,
Carrera-Silva Eugenio Antonio,
Heller Paula Graciela,
Schattner Mirta
Publication year - 2019
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/jth.14605
Subject(s) - thrombopoiesis , thrombopoietin , tlr2 , megakaryocyte , chemistry , medicine , microbiology and biotechnology , endocrinology , receptor , biology , tlr4 , progenitor cell , haematopoiesis , stem cell
Background Platelet Toll‐like receptor (TLR) 2/4 are key players in amplifying the host immune response; however, their role in human megakaryo/thrombopoiesis has not yet been defined. Objectives We evaluated whether Pam3 CSK 4 or lipopolysaccharide ( LPS ), TLR 2/4 ligands respectively, modulate human megakaryocyte development and platelet production. Methods CD 34 + cells from human umbilical cord were stimulated with LPS or Pam3 CSK 4 with or without thrombopoietin ( TPO ). Results CD 34 + cells and megakaryocytes express TLR 2 and TLR 4 at both RNA and protein level; however, direct stimulation of CD 34 + cells with LPS or Pam3 CSK 4 had no effect on cell growth. Interestingly, both TLR ligands markedly increased TPO ‐induced CD 34 + cell proliferation, megakaryocyte number and maturity, proplatelet and platelet production when added at day 0. In contrast, this synergism was not observed when TLR agonists were added 7 days after TPO addition. Interleukin‐6 ( IL ‐6) release was observed upon CD 34 + or megakaryocyte stimulation with LPS or Pam3 CSK 4 but not with TPO and this effect was potentiated in combination with TPO . The increased proliferation and IL ‐6 production induced by TPO  +  LPS or Pam3 CSK 4 were suppressed by TLR 2/4 or IL ‐6 neutralizing antibodies, as well as by PI 3K/ AKT and nuclear factor ‐κB inhibitors. Additionally, increased proplatelet and platelet production were associated with enhanced nuclear translocation of nuclear factor ‐E2. Finally, the supernatants of CD 34 + cells stimulated with TPO + LPS ‐induced CFU ‐M colonies. Conclusions Our data suggest that the activation of TLR 2 and TLR 4 in CD 34 + cells and megakaryocytes in the presence of TPO may contribute to warrant platelet provision during infection episodes by an autocrine IL ‐6 loop triggered by PI 3K/ NF ‐κB axes.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom